wu-nk-101,Cetuximab
wugen,eli lilly
['wu-nk-101', 'wugen']
wugen presents new preclinical data reinforcing anti-tumor functionality of wu-nk-101 at the american association for cancer research (aacr) annual meeting 2023 
Pharmaceutical News - Direct Information